Drug profile · INN
indomethacin sodium
INDOMETHACIN SODIUM
indomethacin sodium (INDOMETHACIN SODIUM) is a cyclooxygenase inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — indomethacin sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
indomethacin sodium (INDOMETHACIN SODIUM) is a cyclooxygenase inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is indomethacin sodium?
indomethacin sodium (INDOMETHACIN SODIUM) is a cyclooxygenase inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for indomethacin sodium?
INDOMETHACIN SODIUM is a marketed brand name for indomethacin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of indomethacin sodium?
indomethacin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.